Vanda Pharmaceuticals
VNDA
#8782
Rank
ยฃ0.17 B
Marketcap
ยฃ2.84
Share price
6.41%
Change (1 day)
-15.09%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -ยฃ0.14 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.21 Billion. In 2025 the company made an earning of -ยฃ0.12 Billion a decrease over its 2024 earnings that were of -ยฃ30.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.14 Billion24.01%
2025 -ยฃ0.12 Billion271.79%
2024 -ยฃ30.22 Million191.43%
2023 -ยฃ10.37 Million-320.45%
2022 ยฃ4.7 M-84.99%
2021 ยฃ31.33 M54.8%
2020 ยฃ20.24 M19.42%
2019 ยฃ16.95 M4.93%
2018 ยฃ16.15 M-228.6%
2017 -ยฃ12.57 Million-8.98%
2016 -ยฃ13.81 Million-53.79%
2015 -ยฃ29.87 Million-30.18%
2014 -ยฃ42.78 Million173.08%
2013 -ยฃ15.67 Million-25.33%
2012 -ยฃ20.98 Million163.61%
2011 -ยฃ7.96 Million-221.15%
2010 ยฃ6.56 M-124.53%
2009 -ยฃ26.78 Million-29.44%
2008 -ยฃ37.95 Million-36.2%
2007 -ยฃ59.49 Million21.81%
2006 -ยฃ48.84 Million170.55%
2005 -ยฃ18.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ13.91 B-10,182.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ9.39 B-6,909.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ5.13 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ25.83 B-18,826.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.71 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.42 B-6,203.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-ยฃ2.09 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA